Skip to main content

Table 2 Subgroup analysis for NLR in UTUC patients

From: Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis

Subgroup

No. of studies

No. of patients

HR (95% CI)

P value

Heterogeneity

Effect model

I2 (%)

Ph

Overall

17

8672

1.66 (1.39–1.98)

< 0.001

53

0.006

Random

Region

 Europe

2

2476

1.58 (0.64–3.88)

0.32

80

0.02

Random

 Asia

15

6196

1.73 (1.52–1.96)

< 0.001

17

0.26

Fixed

Sample size

 ≥ 200

13

8110

1.58 (1.31–1.91)

< 0.001

57

0.006

Random

 < 200

4

562

2.28 (1.49–3.28)

< 0.001

0

0.43

Fixed

Median age (years)

 ≥ 70

5

1818

1.59 (1.25–2.03)

< 0.001

0

0.43

Fixed

 < 70

11

6620

1.62 (1.30–2.01)

< 0.001

60

0.005

Random

Cutoff value of NLR

 > 2.70

6

1986

1.60 (1.26–2.02)

< 0.001

0

0.42

Fixed

 ≤ 2.70

11

6686

1.78 (1.53–2.07)

< 0.001

8

0.37

Fixed

Median time of follow-up (months)

 ≥ 36

11

6692

1.77 (1.41–2.22)

< 0.001

61

0.004

Random

 < 36

5

1890

1.47 (1.16–1.87)

0.002

49

0.10

Fixed

Quality of study

 High

16

8582

1.67 (1.39–2.01)

< 0.001

56

0.003

Random

 Moderate

1

90

-

-

-

-

-